Nubequo Tablets 300mg, with the ingredient Darolutamide, are produced by Bayer Pharmaceutical. This medication (YJ code: 4291063F1025, 300mg x 1 tablet) is an androgen receptor inhibitor indicated for the treatment of adults with non-metastatic castration-resistant prostate cancer (nmCRPC), metastatic castration-sensitive prostate cancer (mCSPC), and mCSPC in combination with docetaxel.
Nubequo Tablets 300mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).